公司概覽
業務類別 Biotechnology
業務概覽 Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
公司地址 5871 Oberlin Drive, Suite 200, San Diego, CA, USA, 92121
電話號碼 +1 858 283-9472
傳真號碼 --
公司網頁 https://www.adarx.com
員工數量 100
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Zhen Li, PhD President, Chief Executive Officer and Director -- 04/09/2026
Mr. Ryan Fisk, M.B.A. Chief Financial Officer and Chief Business Officer -- 04/09/2026
Dr. A Robert MacLeod, PhD Chief Scientific Officer -- 04/09/2026
Dr. Rui Zhu, PhD Chief Technology Officer -- 04/09/2026
Mr. Robert Ackles Chief People Officer -- 04/09/2026
 
董事會成員
董事會 職務 更新日期
Dr. Carl L. Gordon, C.F.A.,PhD Independent Director 04/09/2026
Dr. Mary A. Tagliaferri, M.D. Independent Director 04/09/2026
Dr. Simeon J. George, M.B.A.,M.D. Independent Director 04/09/2026
Mr. Erez Chimovits, M.B.A.,M.Sc. Interim Chairman of the board 04/09/2026
Dr. Zhen Li, PhD President, Chief Executive Officer and Director 04/09/2026
Ms. Judith J. Li, M.B.A. Independent Director 04/09/2026
Dr. Ricky L. Sun, M.B.A.,PhD Independent Director 04/09/2026
Dr. Ying Huang, PhD Independent Director 04/09/2026
Dr. Ting Feng Independent Director 04/09/2026
Dr. Chen Yu, M.B.A. Independent Director 04/09/2026
 
所屬ETF (更新日期: 07/11/2026 03:34)
代號 名稱 佔比% ▼ 持有日期
TMEDT. Rowe Price Health Care ETF0.003%31/10/2026
TDNAT. Rowe Price Biotech ETF0.001%31/10/2026
TSEET. Rowe Price Small-Cap ETF0.0004%31/10/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.